2018-06-20 17:36:53,526:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:36:53,526:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:36:53,526:INFO: ======================================
2018-06-20 17:36:53,526:INFO: Loading PPI Network...
2018-06-20 17:37:16,164:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:37:16,165:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:37:16,165:INFO: ======================================
2018-06-20 17:37:16,165:INFO: Loading PPI Network...
2018-06-20 17:37:26,390:INFO: Loading Disease Associations...
2018-06-20 17:37:26,428:INFO: Loading PPI Matrix...
2018-06-20 17:38:00,075:INFO: Running Experiment...
2018-06-20 17:38:00,078:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 17:38:59,552:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:38:59,552:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:38:59,552:INFO: ======================================
2018-06-20 17:38:59,552:INFO: Loading PPI Network...
2018-06-20 17:39:08,805:INFO: Loading Disease Associations...
2018-06-20 17:39:08,841:INFO: Loading PPI Matrix...
2018-06-20 17:39:36,547:INFO: Running Experiment...
2018-06-20 17:39:36,574:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 17:40:06,392:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:40:06,392:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:40:06,392:INFO: ======================================
2018-06-20 17:40:06,392:INFO: Loading PPI Network...
2018-06-20 17:40:15,183:INFO: Loading Disease Associations...
2018-06-20 17:40:15,218:INFO: Loading PPI Matrix...
2018-06-20 17:40:43,970:INFO: Running Experiment...
2018-06-20 17:40:43,972:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 17:41:14,395:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:41:14,395:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:41:14,395:INFO: ======================================
2018-06-20 17:41:14,395:INFO: Loading PPI Network...
2018-06-20 17:41:23,588:INFO: Loading Disease Associations...
2018-06-20 17:41:23,624:INFO: Loading PPI Matrix...
2018-06-20 17:41:53,966:INFO: Running Experiment...
2018-06-20 17:41:53,968:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 17:46:50,395:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 17:46:50,395:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 17:46:50,395:INFO: ======================================
2018-06-20 17:46:50,396:INFO: Loading PPI Network...
2018-06-20 18:16:14,110:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 18:16:14,110:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 18:16:14,110:INFO: ======================================
2018-06-20 18:16:14,110:INFO: Loading PPI Network...
2018-06-20 18:16:26,965:INFO: Loading Disease Associations...
2018-06-20 18:16:27,003:INFO: Loading PPI Matrix...
2018-06-20 18:16:46,370:INFO: Running Experiment...
2018-06-20 18:16:46,370:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 18:16:46,756:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 0.00%
2018-06-20 18:16:46,757:INFO: Experiment Progress: 0.0% -- 1/519
2018-06-20 18:16:47,172:INFO: Psychoses, Substance-Induced Recall-at-100: 10.00%
2018-06-20 18:16:47,172:INFO: Experiment Progress: 0.0% -- 2/519
2018-06-20 18:16:47,526:INFO: Zellweger Syndrome Recall-at-100: 100.00%
2018-06-20 18:16:47,526:INFO: Experiment Progress: 0.0% -- 3/519
2018-06-20 18:16:48,359:INFO: Psoriasis Recall-at-100: 9.76%
2018-06-20 18:16:48,359:INFO: Experiment Progress: 0.0% -- 4/519
2018-06-20 18:16:48,789:INFO: Nephrotic Syndrome Recall-at-100: 25.00%
2018-06-20 18:16:48,789:INFO: Experiment Progress: 0.0% -- 5/519
2018-06-20 18:16:49,177:INFO: Nephrosis Recall-at-100: 5.00%
2018-06-20 18:16:49,177:INFO: Experiment Progress: 1.0% -- 6/519
2018-06-20 18:16:49,644:INFO: Mouth Diseases Recall-at-100: 25.00%
2018-06-20 18:16:49,644:INFO: Experiment Progress: 1.0% -- 7/519
2018-06-20 18:16:50,107:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 81.67%
2018-06-20 18:16:50,107:INFO: Experiment Progress: 1.0% -- 8/519
2018-06-20 18:16:51,416:INFO: Substance-Related Disorders Recall-at-100: 2.00%
2018-06-20 18:16:51,416:INFO: Experiment Progress: 1.0% -- 9/519
2018-06-20 18:16:51,772:INFO: Anemia, Hemolytic Recall-at-100: 10.00%
2018-06-20 18:16:51,772:INFO: Experiment Progress: 1.0% -- 10/519
2018-06-20 18:16:53,557:INFO: Rheumatoid Arthritis Recall-at-100: 0.98%
2018-06-20 18:16:53,557:INFO: Experiment Progress: 2.0% -- 11/519
2018-06-20 18:16:53,970:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-06-20 18:16:53,970:INFO: Experiment Progress: 2.0% -- 12/519
2018-06-20 18:16:54,437:INFO: Anemia Recall-at-100: 0.00%
2018-06-20 18:16:54,438:INFO: Experiment Progress: 2.0% -- 13/519
2018-06-20 18:16:54,944:INFO: Cholangiocarcinoma Recall-at-100: 11.67%
2018-06-20 18:16:54,944:INFO: Experiment Progress: 2.0% -- 14/519
2018-06-20 18:16:55,288:INFO: Neuroendocrine Tumors Recall-at-100: 40.00%
2018-06-20 18:16:55,288:INFO: Experiment Progress: 2.0% -- 15/519
2018-06-20 18:16:55,720:INFO: Malaria Recall-at-100: 0.00%
2018-06-20 18:16:55,720:INFO: Experiment Progress: 3.0% -- 16/519
2018-06-20 18:16:56,054:INFO: Hyperhomocysteinemia Recall-at-100: 0.00%
2018-06-20 18:16:56,054:INFO: Experiment Progress: 3.0% -- 17/519
2018-06-20 18:16:57,036:INFO: HIV Infections Recall-at-100: 21.00%
2018-06-20 18:16:57,036:INFO: Experiment Progress: 3.0% -- 18/519
2018-06-20 18:16:57,395:INFO: Ankylosing spondylitis Recall-at-100: 25.00%
2018-06-20 18:16:57,395:INFO: Experiment Progress: 3.0% -- 19/519
2018-06-20 18:16:58,396:INFO: Adenoid Cystic Carcinoma Recall-at-100: 7.67%
2018-06-20 18:16:58,396:INFO: Experiment Progress: 3.0% -- 20/519
2018-06-20 18:16:59,650:INFO: Juvenile arthritis Recall-at-100: 4.87%
2018-06-20 18:16:59,650:INFO: Experiment Progress: 4.0% -- 21/519
2018-06-20 18:17:00,289:INFO: Neoplasms, Experimental Recall-at-100: 5.83%
2018-06-20 18:17:00,289:INFO: Experiment Progress: 4.0% -- 22/519
2018-06-20 18:17:00,674:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 35.00%
2018-06-20 18:17:00,675:INFO: Experiment Progress: 4.0% -- 23/519
2018-06-20 18:17:01,003:INFO: Alopecia Areata Recall-at-100: 22.22%
2018-06-20 18:17:01,003:INFO: Experiment Progress: 4.0% -- 24/519
2018-06-20 18:17:01,400:INFO: Alopecia Recall-at-100: 20.00%
2018-06-20 18:17:01,400:INFO: Experiment Progress: 4.0% -- 25/519
2018-06-20 18:17:01,865:INFO: Bradycardia Recall-at-100: 15.00%
2018-06-20 18:17:01,865:INFO: Experiment Progress: 5.0% -- 26/519
2018-06-20 18:17:02,269:INFO: Common Variable Immunodeficiency Recall-at-100: 65.00%
2018-06-20 18:17:02,269:INFO: Experiment Progress: 5.0% -- 27/519
2018-06-20 18:17:02,762:INFO: Glomerulonephritis Recall-at-100: 13.33%
2018-06-20 18:17:02,763:INFO: Experiment Progress: 5.0% -- 28/519
2018-06-20 18:17:03,337:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 3.33%
2018-06-20 18:17:03,337:INFO: Experiment Progress: 5.0% -- 29/519
2018-06-20 18:17:03,774:INFO: Lung Injury Recall-at-100: 15.00%
2018-06-20 18:17:03,774:INFO: Experiment Progress: 5.0% -- 30/519
2018-06-20 18:17:04,128:INFO: Hypercalcemia Recall-at-100: 20.00%
2018-06-20 18:17:04,128:INFO: Experiment Progress: 5.0% -- 31/519
2018-06-20 18:17:04,696:INFO: Cerebrovascular accident Recall-at-100: 28.33%
2018-06-20 18:17:04,697:INFO: Experiment Progress: 6.0% -- 32/519
2018-06-20 18:17:05,308:INFO: Diaphragmatic Hernia Recall-at-100: 10.00%
2018-06-20 18:17:05,308:INFO: Experiment Progress: 6.0% -- 33/519
2018-06-20 18:17:05,675:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-06-20 18:17:05,676:INFO: Experiment Progress: 6.0% -- 34/519
2018-06-20 18:17:06,163:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-06-20 18:17:06,163:INFO: Experiment Progress: 6.0% -- 35/519
2018-06-20 18:17:06,349:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-06-20 18:17:06,349:INFO: Experiment Progress: 6.0% -- 36/519
2018-06-20 18:17:06,736:INFO: Brugada Syndrome (disorder) Recall-at-100: 10.00%
2018-06-20 18:17:06,737:INFO: Experiment Progress: 7.0% -- 37/519
2018-06-20 18:17:07,100:INFO: Pathological accumulation of air in tissues Recall-at-100: 30.00%
2018-06-20 18:17:07,100:INFO: Experiment Progress: 7.0% -- 38/519
2018-06-20 18:17:07,485:INFO: Craniosynostosis Recall-at-100: 15.00%
2018-06-20 18:17:07,486:INFO: Experiment Progress: 7.0% -- 39/519
2018-06-20 18:17:07,938:INFO: Head and Neck Neoplasms Recall-at-100: 10.00%
2018-06-20 18:17:07,939:INFO: Experiment Progress: 7.0% -- 40/519
2018-06-20 18:17:08,432:INFO: Brain Neoplasms Recall-at-100: 18.33%
2018-06-20 18:17:08,432:INFO: Experiment Progress: 7.0% -- 41/519
2018-06-20 18:17:08,885:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-06-20 18:17:08,885:INFO: Experiment Progress: 8.0% -- 42/519
2018-06-20 18:17:09,303:INFO: Chromosome Aberrations Recall-at-100: 0.00%
2018-06-20 18:17:09,303:INFO: Experiment Progress: 8.0% -- 43/519
2018-06-20 18:17:09,997:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 6.00%
2018-06-20 18:17:09,997:INFO: Experiment Progress: 8.0% -- 44/519
2018-06-20 18:17:10,382:INFO: Refractive Errors Recall-at-100: 0.00%
2018-06-20 18:17:10,382:INFO: Experiment Progress: 8.0% -- 45/519
2018-06-20 18:17:10,777:INFO: Hepatitis C Recall-at-100: 5.00%
2018-06-20 18:17:10,778:INFO: Experiment Progress: 8.0% -- 46/519
2018-06-20 18:17:11,384:INFO: Mesothelioma Recall-at-100: 7.50%
2018-06-20 18:17:11,385:INFO: Experiment Progress: 9.0% -- 47/519
2018-06-20 18:17:11,654:INFO: Noise-induced hearing loss Recall-at-100: 37.50%
2018-06-20 18:17:11,654:INFO: Experiment Progress: 9.0% -- 48/519
2018-06-20 18:17:12,181:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-06-20 18:17:12,181:INFO: Experiment Progress: 9.0% -- 49/519
2018-06-20 18:17:12,586:INFO: Kallmann Syndrome Recall-at-100: 5.00%
2018-06-20 18:17:12,586:INFO: Experiment Progress: 9.0% -- 50/519
2018-06-20 18:17:13,013:INFO: Lipoidosis Recall-at-100: 0.00%
2018-06-20 18:17:13,013:INFO: Experiment Progress: 9.0% -- 51/519
2018-06-20 18:17:13,516:INFO: Diabetes Mellitus Recall-at-100: 15.00%
2018-06-20 18:17:13,516:INFO: Experiment Progress: 10.0% -- 52/519
2018-06-20 18:17:14,116:INFO: Fibrosis Recall-at-100: 20.00%
2018-06-20 18:17:14,116:INFO: Experiment Progress: 10.0% -- 53/519
2018-06-20 18:17:14,563:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-06-20 18:17:14,563:INFO: Experiment Progress: 10.0% -- 54/519
2018-06-20 18:17:15,028:INFO: Microcephaly Recall-at-100: 15.00%
2018-06-20 18:17:15,028:INFO: Experiment Progress: 10.0% -- 55/519
2018-06-20 18:17:15,397:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-06-20 18:17:15,397:INFO: Experiment Progress: 10.0% -- 56/519
2018-06-20 18:17:15,783:INFO: Common Migraine Recall-at-100: 0.00%
2018-06-20 18:17:15,783:INFO: Experiment Progress: 10.0% -- 57/519
2018-06-20 18:17:16,148:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-06-20 18:17:16,148:INFO: Experiment Progress: 11.0% -- 58/519
2018-06-20 18:17:16,685:INFO: Growth Disorders Recall-at-100: 5.83%
2018-06-20 18:17:16,685:INFO: Experiment Progress: 11.0% -- 59/519
2018-06-20 18:17:16,993:INFO: Absence Epilepsy Recall-at-100: 22.22%
2018-06-20 18:17:16,993:INFO: Experiment Progress: 11.0% -- 60/519
2018-06-20 18:17:17,416:INFO: Epilepsy, Temporal Lobe Recall-at-100: 5.00%
2018-06-20 18:17:17,416:INFO: Experiment Progress: 11.0% -- 61/519
2018-06-20 18:17:17,964:INFO: Memory Disorders Recall-at-100: 20.00%
2018-06-20 18:17:17,964:INFO: Experiment Progress: 11.0% -- 62/519
2018-06-20 18:17:18,329:INFO: Catalepsy Recall-at-100: 5.00%
2018-06-20 18:17:18,329:INFO: Experiment Progress: 12.0% -- 63/519
2018-06-20 18:17:18,715:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 45.00%
2018-06-20 18:17:18,715:INFO: Experiment Progress: 12.0% -- 64/519
2018-06-20 18:17:19,225:INFO: Acute Promyelocytic Leukemia Recall-at-100: 10.00%
2018-06-20 18:17:19,225:INFO: Experiment Progress: 12.0% -- 65/519
2018-06-20 18:17:19,579:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-06-20 18:17:19,580:INFO: Experiment Progress: 12.0% -- 66/519
2018-06-20 18:17:19,912:INFO: Gout Recall-at-100: 0.00%
2018-06-20 18:17:19,913:INFO: Experiment Progress: 12.0% -- 67/519
2018-06-20 18:17:20,663:INFO: Coronary Artery Disease Recall-at-100: 5.33%
2018-06-20 18:17:20,663:INFO: Experiment Progress: 13.0% -- 68/519
2018-06-20 18:17:21,215:INFO: Venous Thromboembolism Recall-at-100: 20.00%
2018-06-20 18:17:21,215:INFO: Experiment Progress: 13.0% -- 69/519
2018-06-20 18:17:22,105:INFO: Precancerous Conditions Recall-at-100: 2.50%
2018-06-20 18:17:22,105:INFO: Experiment Progress: 13.0% -- 70/519
2018-06-20 18:17:23,058:INFO: Crohn Disease Recall-at-100: 3.61%
2018-06-20 18:17:23,058:INFO: Experiment Progress: 13.0% -- 71/519
2018-06-20 18:17:23,510:INFO: Uterine Cervical Neoplasm Recall-at-100: 23.33%
2018-06-20 18:17:23,510:INFO: Experiment Progress: 13.0% -- 72/519
2018-06-20 18:17:23,914:INFO: Dyskinesia, Drug-Induced Recall-at-100: 20.00%
2018-06-20 18:17:23,914:INFO: Experiment Progress: 14.0% -- 73/519
2018-06-20 18:17:24,336:INFO: Ataxia, Spinocerebellar Recall-at-100: 40.00%
2018-06-20 18:17:24,336:INFO: Experiment Progress: 14.0% -- 74/519
2018-06-20 18:17:24,446:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 0.00%
2018-06-20 18:17:24,446:INFO: Experiment Progress: 14.0% -- 75/519
2018-06-20 18:17:24,844:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 5.00%
2018-06-20 18:17:24,844:INFO: Experiment Progress: 14.0% -- 76/519
2018-06-20 18:17:25,243:INFO: Acute Lung Injury Recall-at-100: 10.00%
2018-06-20 18:17:25,243:INFO: Experiment Progress: 14.0% -- 77/519
2018-06-20 18:17:26,335:INFO: Liver Cirrhosis, Experimental Recall-at-100: 3.82%
2018-06-20 18:17:26,335:INFO: Experiment Progress: 15.0% -- 78/519
2018-06-20 18:17:26,875:INFO: Chloracne Recall-at-100: 10.00%
2018-06-20 18:17:26,875:INFO: Experiment Progress: 15.0% -- 79/519
2018-06-20 18:17:27,671:INFO: Liver diseases Recall-at-100: 1.67%
2018-06-20 18:17:27,671:INFO: Experiment Progress: 15.0% -- 80/519
2018-06-20 18:17:28,299:INFO: Kidney Failure, Chronic Recall-at-100: 7.00%
2018-06-20 18:17:28,299:INFO: Experiment Progress: 15.0% -- 81/519
2018-06-20 18:17:28,728:INFO: Weight decreased Recall-at-100: 10.00%
2018-06-20 18:17:28,728:INFO: Experiment Progress: 15.0% -- 82/519
2018-06-20 18:17:29,190:INFO: Leigh Disease Recall-at-100: 40.00%
2018-06-20 18:17:29,191:INFO: Experiment Progress: 15.0% -- 83/519
2018-06-20 18:17:29,736:INFO: Celiac Disease Recall-at-100: 8.33%
2018-06-20 18:17:29,736:INFO: Experiment Progress: 16.0% -- 84/519
2018-06-20 18:17:30,203:INFO: Glaucoma Recall-at-100: 0.00%
2018-06-20 18:17:30,203:INFO: Experiment Progress: 16.0% -- 85/519
2018-06-20 18:17:30,623:INFO: Tachycardia Recall-at-100: 0.00%
2018-06-20 18:17:30,623:INFO: Experiment Progress: 16.0% -- 86/519
2018-06-20 18:17:31,067:INFO: Breast Cancer, Familial Recall-at-100: 85.00%
2018-06-20 18:17:31,067:INFO: Experiment Progress: 16.0% -- 87/519
2018-06-20 18:17:31,644:INFO: Ischemia Recall-at-100: 5.00%
2018-06-20 18:17:31,645:INFO: Experiment Progress: 16.0% -- 88/519
2018-06-20 18:17:31,943:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-06-20 18:17:31,944:INFO: Experiment Progress: 17.0% -- 89/519
2018-06-20 18:17:32,385:INFO: Thyroid Diseases Recall-at-100: 0.00%
2018-06-20 18:17:32,385:INFO: Experiment Progress: 17.0% -- 90/519
2018-06-20 18:17:32,680:INFO: Panic Disorder Recall-at-100: 0.00%
2018-06-20 18:17:32,680:INFO: Experiment Progress: 17.0% -- 91/519
2018-06-20 18:17:34,914:INFO: Colorectal Neoplasms Recall-at-100: 5.17%
2018-06-20 18:17:34,914:INFO: Experiment Progress: 17.0% -- 92/519
2018-06-20 18:17:35,337:INFO: Adrenal Gland Neoplasms Recall-at-100: 30.00%
2018-06-20 18:17:35,338:INFO: Experiment Progress: 17.0% -- 93/519
2018-06-20 18:17:35,674:INFO: Sudden infant death syndrome Recall-at-100: 33.33%
2018-06-20 18:17:35,674:INFO: Experiment Progress: 18.0% -- 94/519
2018-06-20 18:17:36,376:INFO: Neuroblastoma Recall-at-100: 4.50%
2018-06-20 18:17:36,376:INFO: Experiment Progress: 18.0% -- 95/519
2018-06-20 18:17:36,793:INFO: Prostate cancer, familial Recall-at-100: 10.00%
2018-06-20 18:17:36,793:INFO: Experiment Progress: 18.0% -- 96/519
2018-06-20 18:17:38,263:INFO: Animal Mammary Neoplasms Recall-at-100: 10.49%
2018-06-20 18:17:38,263:INFO: Experiment Progress: 18.0% -- 97/519
2018-06-20 18:17:38,721:INFO: Osteochondrodysplasias Recall-at-100: 25.00%
2018-06-20 18:17:38,722:INFO: Experiment Progress: 18.0% -- 98/519
2018-06-20 18:17:39,234:INFO: Hepatolenticular Degeneration Recall-at-100: 15.00%
2018-06-20 18:17:39,235:INFO: Experiment Progress: 19.0% -- 99/519
2018-06-20 18:17:39,706:INFO: Fanconi Anemia Recall-at-100: 90.00%
2018-06-20 18:17:39,706:INFO: Experiment Progress: 19.0% -- 100/519
2018-06-20 18:17:40,113:INFO: Eye Abnormalities Recall-at-100: 20.00%
2018-06-20 18:17:40,113:INFO: Experiment Progress: 19.0% -- 101/519
2018-06-20 18:17:40,560:INFO: Limb Deformities, Congenital Recall-at-100: 10.00%
2018-06-20 18:17:40,561:INFO: Experiment Progress: 19.0% -- 102/519
2018-06-20 18:17:40,855:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-06-20 18:17:40,855:INFO: Experiment Progress: 19.0% -- 103/519
2018-06-20 18:17:42,561:INFO: Mammary Neoplasms, Experimental Recall-at-100: 8.14%
2018-06-20 18:17:42,562:INFO: Experiment Progress: 20.0% -- 104/519
2018-06-20 18:17:43,085:INFO: Heart valve disease Recall-at-100: 0.00%
2018-06-20 18:17:43,085:INFO: Experiment Progress: 20.0% -- 105/519
2018-06-20 18:17:43,778:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 5.00%
2018-06-20 18:17:43,779:INFO: Experiment Progress: 20.0% -- 106/519
2018-06-20 18:17:44,276:INFO: Hepatitis Recall-at-100: 0.00%
2018-06-20 18:17:44,276:INFO: Experiment Progress: 20.0% -- 107/519
2018-06-20 18:17:44,700:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-06-20 18:17:44,701:INFO: Experiment Progress: 20.0% -- 108/519
2018-06-20 18:17:45,123:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 40.00%
2018-06-20 18:17:45,123:INFO: Experiment Progress: 21.0% -- 109/519
2018-06-20 18:17:45,639:INFO: Colon Carcinoma Recall-at-100: 25.00%
2018-06-20 18:17:45,639:INFO: Experiment Progress: 21.0% -- 110/519
2018-06-20 18:17:46,047:INFO: Hepatic Encephalopathy Recall-at-100: 0.00%
2018-06-20 18:17:46,047:INFO: Experiment Progress: 21.0% -- 111/519
2018-06-20 18:17:47,130:INFO: Multiple Sclerosis Recall-at-100: 5.00%
2018-06-20 18:17:47,130:INFO: Experiment Progress: 21.0% -- 112/519
2018-06-20 18:17:47,599:INFO: Neurogenic Inflammation Recall-at-100: 0.00%
2018-06-20 18:17:47,599:INFO: Experiment Progress: 21.0% -- 113/519
2018-06-20 18:17:48,508:INFO: Lupus Erythematosus, Systemic Recall-at-100: 1.25%
2018-06-20 18:17:48,508:INFO: Experiment Progress: 21.0% -- 114/519
2018-06-20 18:17:48,934:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 20.00%
2018-06-20 18:17:48,934:INFO: Experiment Progress: 22.0% -- 115/519
2018-06-20 18:17:49,598:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 9.00%
2018-06-20 18:17:49,598:INFO: Experiment Progress: 22.0% -- 116/519
2018-06-20 18:17:50,167:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-06-20 18:17:50,167:INFO: Experiment Progress: 22.0% -- 117/519
2018-06-20 18:17:50,573:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-06-20 18:17:50,573:INFO: Experiment Progress: 22.0% -- 118/519
2018-06-20 18:17:50,980:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-06-20 18:17:50,981:INFO: Experiment Progress: 22.0% -- 119/519
2018-06-20 18:17:51,525:INFO: Hepatitis, Autoimmune Recall-at-100: 30.00%
2018-06-20 18:17:51,525:INFO: Experiment Progress: 23.0% -- 120/519
2018-06-20 18:17:56,157:INFO: Prostatic Neoplasms Recall-at-100: 5.15%
2018-06-20 18:17:56,157:INFO: Experiment Progress: 23.0% -- 121/519
2018-06-20 18:17:56,634:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 85.00%
2018-06-20 18:17:56,634:INFO: Experiment Progress: 23.0% -- 122/519
2018-06-20 18:17:57,084:INFO: Hypospadias Recall-at-100: 0.00%
2018-06-20 18:17:57,084:INFO: Experiment Progress: 23.0% -- 123/519
2018-06-20 18:17:57,746:INFO: Multiple Myeloma Recall-at-100: 14.17%
2018-06-20 18:17:57,746:INFO: Experiment Progress: 23.0% -- 124/519
2018-06-20 18:17:58,575:INFO: Fatty Liver Recall-at-100: 7.67%
2018-06-20 18:17:58,576:INFO: Experiment Progress: 24.0% -- 125/519
2018-06-20 18:17:58,983:INFO: Leishmaniasis, Visceral Recall-at-100: 15.00%
2018-06-20 18:17:58,984:INFO: Experiment Progress: 24.0% -- 126/519
2018-06-20 18:17:59,448:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 5.00%
2018-06-20 18:17:59,448:INFO: Experiment Progress: 24.0% -- 127/519
2018-06-20 18:18:00,014:INFO: Kartagener Syndrome Recall-at-100: 0.00%
2018-06-20 18:18:00,014:INFO: Experiment Progress: 24.0% -- 128/519
2018-06-20 18:18:00,455:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 35.00%
2018-06-20 18:18:00,455:INFO: Experiment Progress: 24.0% -- 129/519
2018-06-20 18:18:01,348:INFO: Bipolar Disorder Recall-at-100: 3.33%
2018-06-20 18:18:01,348:INFO: Experiment Progress: 25.0% -- 130/519
2018-06-20 18:18:01,752:INFO: Erectile dysfunction Recall-at-100: 60.00%
2018-06-20 18:18:01,753:INFO: Experiment Progress: 25.0% -- 131/519
2018-06-20 18:18:02,211:INFO: Meckel-Gruber syndrome Recall-at-100: 90.00%
2018-06-20 18:18:02,211:INFO: Experiment Progress: 25.0% -- 132/519
2018-06-20 18:18:03,603:INFO: Colonic Neoplasms Recall-at-100: 10.38%
2018-06-20 18:18:03,603:INFO: Experiment Progress: 25.0% -- 133/519
2018-06-20 18:18:05,775:INFO: Autistic Disorder Recall-at-100: 2.21%
2018-06-20 18:18:05,775:INFO: Experiment Progress: 25.0% -- 134/519
2018-06-20 18:18:06,633:INFO: Liver Neoplasms, Experimental Recall-at-100: 24.29%
2018-06-20 18:18:06,634:INFO: Experiment Progress: 26.0% -- 135/519
2018-06-20 18:18:07,116:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-06-20 18:18:07,116:INFO: Experiment Progress: 26.0% -- 136/519
2018-06-20 18:18:07,525:INFO: Narcolepsy Recall-at-100: 5.00%
2018-06-20 18:18:07,525:INFO: Experiment Progress: 26.0% -- 137/519
2018-06-20 18:18:08,018:INFO: Fever Recall-at-100: 0.00%
2018-06-20 18:18:08,018:INFO: Experiment Progress: 26.0% -- 138/519
2018-06-20 18:18:09,237:INFO: Adenocarcinoma Recall-at-100: 10.45%
2018-06-20 18:18:09,237:INFO: Experiment Progress: 26.0% -- 139/519
2018-06-20 18:18:09,656:INFO: Aortic Valve Insufficiency Recall-at-100: 50.00%
2018-06-20 18:18:09,657:INFO: Experiment Progress: 26.0% -- 140/519
2018-06-20 18:18:10,164:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 20.00%
2018-06-20 18:18:10,165:INFO: Experiment Progress: 27.0% -- 141/519
2018-06-20 18:18:10,706:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 15.00%
2018-06-20 18:18:10,706:INFO: Experiment Progress: 27.0% -- 142/519
2018-06-20 18:18:12,702:INFO: Hypertensive disease Recall-at-100: 8.22%
2018-06-20 18:18:12,703:INFO: Experiment Progress: 27.0% -- 143/519
2018-06-20 18:18:13,239:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 20.00%
2018-06-20 18:18:13,239:INFO: Experiment Progress: 27.0% -- 144/519
2018-06-20 18:18:13,706:INFO: Leprosy Recall-at-100: 5.00%
2018-06-20 18:18:13,707:INFO: Experiment Progress: 27.0% -- 145/519
2018-06-20 18:18:14,775:INFO: Myocardial Infarction Recall-at-100: 4.72%
2018-06-20 18:18:14,775:INFO: Experiment Progress: 28.0% -- 146/519
2018-06-20 18:18:15,203:INFO: Urticaria Recall-at-100: 10.00%
2018-06-20 18:18:15,203:INFO: Experiment Progress: 28.0% -- 147/519
2018-06-20 18:18:15,749:INFO: Cardiac Arrhythmia Recall-at-100: 0.00%
2018-06-20 18:18:15,749:INFO: Experiment Progress: 28.0% -- 148/519
2018-06-20 18:18:16,130:INFO: Hemochromatosis Recall-at-100: 20.00%
2018-06-20 18:18:16,130:INFO: Experiment Progress: 28.0% -- 149/519
2018-06-20 18:18:17,076:INFO: Pancreatic Neoplasm Recall-at-100: 12.68%
2018-06-20 18:18:17,076:INFO: Experiment Progress: 28.0% -- 150/519
2018-06-20 18:18:17,752:INFO: Cardiomyopathy, Dilated Recall-at-100: 16.50%
2018-06-20 18:18:17,752:INFO: Experiment Progress: 29.0% -- 151/519
2018-06-20 18:18:18,180:INFO: Papilloma Recall-at-100: 20.00%
2018-06-20 18:18:18,180:INFO: Experiment Progress: 29.0% -- 152/519
2018-06-20 18:18:18,825:INFO: Pain Recall-at-100: 5.00%
2018-06-20 18:18:18,825:INFO: Experiment Progress: 29.0% -- 153/519
2018-06-20 18:18:19,166:INFO: Congenital Abnormality Recall-at-100: 0.00%
2018-06-20 18:18:19,166:INFO: Experiment Progress: 29.0% -- 154/519
2018-06-20 18:18:19,548:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 25.00%
2018-06-20 18:18:19,548:INFO: Experiment Progress: 29.0% -- 155/519
2018-06-20 18:18:20,540:INFO: Kidney Diseases Recall-at-100: 1.11%
2018-06-20 18:18:20,541:INFO: Experiment Progress: 30.0% -- 156/519
2018-06-20 18:18:20,990:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-06-20 18:18:20,990:INFO: Experiment Progress: 30.0% -- 157/519
2018-06-20 18:18:21,454:INFO: Basal cell carcinoma Recall-at-100: 5.00%
2018-06-20 18:18:21,454:INFO: Experiment Progress: 30.0% -- 158/519
2018-06-20 18:18:23,514:INFO: Liver carcinoma Recall-at-100: 9.76%
2018-06-20 18:18:23,514:INFO: Experiment Progress: 30.0% -- 159/519
2018-06-20 18:18:23,959:INFO: gliosarcoma Recall-at-100: 15.00%
2018-06-20 18:18:23,960:INFO: Experiment Progress: 30.0% -- 160/519
2018-06-20 18:18:24,523:INFO: Acute Coronary Syndrome Recall-at-100: 25.00%
2018-06-20 18:18:24,523:INFO: Experiment Progress: 31.0% -- 161/519
2018-06-20 18:18:25,087:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-06-20 18:18:25,088:INFO: Experiment Progress: 31.0% -- 162/519
2018-06-20 18:18:25,518:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-06-20 18:18:25,518:INFO: Experiment Progress: 31.0% -- 163/519
2018-06-20 18:18:26,041:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-06-20 18:18:26,041:INFO: Experiment Progress: 31.0% -- 164/519
2018-06-20 18:18:28,299:INFO: Schizophrenia Recall-at-100: 2.14%
2018-06-20 18:18:28,299:INFO: Experiment Progress: 31.0% -- 165/519
2018-06-20 18:18:28,670:INFO: Atrophic Recall-at-100: 0.00%
2018-06-20 18:18:28,670:INFO: Experiment Progress: 31.0% -- 166/519
2018-06-20 18:18:29,098:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 0.00%
2018-06-20 18:18:29,098:INFO: Experiment Progress: 32.0% -- 167/519
2018-06-20 18:18:29,476:INFO: Lobar Holoprosencephaly Recall-at-100: 0.00%
2018-06-20 18:18:29,476:INFO: Experiment Progress: 32.0% -- 168/519
2018-06-20 18:18:29,874:INFO: Alobar Holoprosencephaly Recall-at-100: 0.00%
2018-06-20 18:18:29,874:INFO: Experiment Progress: 32.0% -- 169/519
2018-06-20 18:18:30,262:INFO: Immunologic Deficiency Syndromes Recall-at-100: 35.00%
2018-06-20 18:18:30,262:INFO: Experiment Progress: 32.0% -- 170/519
2018-06-20 18:18:30,625:INFO: Ataxia Recall-at-100: 20.00%
2018-06-20 18:18:30,625:INFO: Experiment Progress: 32.0% -- 171/519
2018-06-20 18:18:31,038:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-06-20 18:18:31,038:INFO: Experiment Progress: 33.0% -- 172/519
2018-06-20 18:18:31,844:INFO: Retinitis Pigmentosa Recall-at-100: 12.38%
2018-06-20 18:18:31,844:INFO: Experiment Progress: 33.0% -- 173/519
2018-06-20 18:18:32,776:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 11.25%
2018-06-20 18:18:32,776:INFO: Experiment Progress: 33.0% -- 174/519
2018-06-20 18:18:33,327:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-06-20 18:18:33,327:INFO: Experiment Progress: 33.0% -- 175/519
2018-06-20 18:18:33,645:INFO: Diarrhea Recall-at-100: 11.11%
2018-06-20 18:18:33,646:INFO: Experiment Progress: 33.0% -- 176/519
2018-06-20 18:18:35,274:INFO: Myocardial Ischemia Recall-at-100: 4.15%
2018-06-20 18:18:35,274:INFO: Experiment Progress: 34.0% -- 177/519
2018-06-20 18:18:35,690:INFO: Essential Hypertension Recall-at-100: 5.00%
2018-06-20 18:18:35,691:INFO: Experiment Progress: 34.0% -- 178/519
2018-06-20 18:18:35,997:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-06-20 18:18:35,997:INFO: Experiment Progress: 34.0% -- 179/519
2018-06-20 18:18:36,593:INFO: Myopathy Recall-at-100: 5.00%
2018-06-20 18:18:36,593:INFO: Experiment Progress: 34.0% -- 180/519
2018-06-20 18:18:37,298:INFO: Adverse reaction to drug Recall-at-100: 7.33%
2018-06-20 18:18:37,298:INFO: Experiment Progress: 34.0% -- 181/519
2018-06-20 18:18:37,697:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 15.00%
2018-06-20 18:18:37,698:INFO: Experiment Progress: 35.0% -- 182/519
2018-06-20 18:18:38,110:INFO: Muscular Atrophy Recall-at-100: 25.00%
2018-06-20 18:18:38,110:INFO: Experiment Progress: 35.0% -- 183/519
2018-06-20 18:18:38,472:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-06-20 18:18:38,472:INFO: Experiment Progress: 35.0% -- 184/519
2018-06-20 18:18:38,914:INFO: Hepatitis B Recall-at-100: 25.00%
2018-06-20 18:18:38,914:INFO: Experiment Progress: 35.0% -- 185/519
2018-06-20 18:18:39,530:INFO: Lung diseases Recall-at-100: 7.50%
2018-06-20 18:18:39,530:INFO: Experiment Progress: 35.0% -- 186/519
2018-06-20 18:18:40,173:INFO: Chronic Obstructive Airway Disease Recall-at-100: 2.50%
2018-06-20 18:18:40,173:INFO: Experiment Progress: 36.0% -- 187/519
2018-06-20 18:18:42,673:INFO: Peripheral Neuropathy Recall-at-100: 2.25%
2018-06-20 18:18:42,674:INFO: Experiment Progress: 36.0% -- 188/519
2018-06-20 18:18:43,656:INFO: Weight Gain Recall-at-100: 6.94%
2018-06-20 18:18:43,656:INFO: Experiment Progress: 36.0% -- 189/519
2018-06-20 18:18:44,072:INFO: Deafness Recall-at-100: 10.00%
2018-06-20 18:18:44,072:INFO: Experiment Progress: 36.0% -- 190/519
2018-06-20 18:18:44,435:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 40.00%
2018-06-20 18:18:44,435:INFO: Experiment Progress: 36.0% -- 191/519
2018-06-20 18:18:44,974:INFO: Attention deficit hyperactivity disorder Recall-at-100: 0.00%
2018-06-20 18:18:44,974:INFO: Experiment Progress: 36.0% -- 192/519
2018-06-20 18:18:45,355:INFO: Tetralogy of Fallot Recall-at-100: 50.00%
2018-06-20 18:18:45,355:INFO: Experiment Progress: 37.0% -- 193/519
2018-06-20 18:18:45,918:INFO: Neurodegenerative Disorders Recall-at-100: 13.33%
2018-06-20 18:18:45,918:INFO: Experiment Progress: 37.0% -- 194/519
2018-06-20 18:18:46,315:INFO: Barrett Esophagus Recall-at-100: 15.00%
2018-06-20 18:18:46,315:INFO: Experiment Progress: 37.0% -- 195/519
2018-06-20 18:18:47,827:INFO: Craniofacial Abnormalities Recall-at-100: 7.10%
2018-06-20 18:18:47,827:INFO: Experiment Progress: 37.0% -- 196/519
2018-06-20 18:18:48,276:INFO: Necrotizing Enterocolitis Recall-at-100: 10.00%
2018-06-20 18:18:48,277:INFO: Experiment Progress: 37.0% -- 197/519
2018-06-20 18:18:48,744:INFO: Hyperlipidemia Recall-at-100: 15.00%
2018-06-20 18:18:48,744:INFO: Experiment Progress: 38.0% -- 198/519
2018-06-20 18:18:49,197:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 0.00%
2018-06-20 18:18:49,197:INFO: Experiment Progress: 38.0% -- 199/519
2018-06-20 18:18:49,710:INFO: Anoxia Recall-at-100: 9.17%
2018-06-20 18:18:49,710:INFO: Experiment Progress: 38.0% -- 200/519
2018-06-20 18:18:50,341:INFO: Small cell carcinoma of lung Recall-at-100: 22.50%
2018-06-20 18:18:50,342:INFO: Experiment Progress: 38.0% -- 201/519
2018-06-20 18:18:51,163:INFO: Epilepsy Recall-at-100: 4.76%
2018-06-20 18:18:51,164:INFO: Experiment Progress: 38.0% -- 202/519
2018-06-20 18:18:51,626:INFO: Liver Failure, Acute Recall-at-100: 18.33%
2018-06-20 18:18:51,626:INFO: Experiment Progress: 39.0% -- 203/519
2018-06-20 18:18:52,094:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 20.00%
2018-06-20 18:18:52,094:INFO: Experiment Progress: 39.0% -- 204/519
2018-06-20 18:18:52,572:INFO: Cognition Disorders Recall-at-100: 5.00%
2018-06-20 18:18:52,573:INFO: Experiment Progress: 39.0% -- 205/519
2018-06-20 18:18:52,953:INFO: Tonic-Clonic Epilepsy Recall-at-100: 0.00%
2018-06-20 18:18:52,953:INFO: Experiment Progress: 39.0% -- 206/519
2018-06-20 18:18:53,599:INFO: Heart Diseases Recall-at-100: 9.50%
2018-06-20 18:18:53,599:INFO: Experiment Progress: 39.0% -- 207/519
2018-06-20 18:18:54,158:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 13.33%
2018-06-20 18:18:54,158:INFO: Experiment Progress: 40.0% -- 208/519
2018-06-20 18:18:54,622:INFO: Primary biliary cirrhosis Recall-at-100: 15.00%
2018-06-20 18:18:54,623:INFO: Experiment Progress: 40.0% -- 209/519
2018-06-20 18:18:55,017:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-06-20 18:18:55,017:INFO: Experiment Progress: 40.0% -- 210/519
2018-06-20 18:18:55,424:INFO: Marijuana Abuse Recall-at-100: 10.00%
2018-06-20 18:18:55,424:INFO: Experiment Progress: 40.0% -- 211/519
2018-06-20 18:18:55,885:INFO: Long QT Syndrome Recall-at-100: 55.00%
2018-06-20 18:18:55,885:INFO: Experiment Progress: 40.0% -- 212/519
2018-06-20 18:18:56,321:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-06-20 18:18:56,321:INFO: Experiment Progress: 41.0% -- 213/519
2018-06-20 18:18:56,669:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 0.00%
2018-06-20 18:18:56,669:INFO: Experiment Progress: 41.0% -- 214/519
2018-06-20 18:18:57,342:INFO: Insulin Resistance Recall-at-100: 14.50%
2018-06-20 18:18:57,342:INFO: Experiment Progress: 41.0% -- 215/519
2018-06-20 18:18:57,899:INFO: Left Ventricular Hypertrophy Recall-at-100: 20.00%
2018-06-20 18:18:57,900:INFO: Experiment Progress: 41.0% -- 216/519
2018-06-20 18:18:58,311:INFO: Bronchial Hyperreactivity Recall-at-100: 15.00%
2018-06-20 18:18:58,311:INFO: Experiment Progress: 41.0% -- 217/519
2018-06-20 18:18:58,989:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 7.00%
2018-06-20 18:18:58,990:INFO: Experiment Progress: 42.0% -- 218/519
2018-06-20 18:18:59,351:INFO: Fetal Growth Retardation Recall-at-100: 0.00%
2018-06-20 18:18:59,352:INFO: Experiment Progress: 42.0% -- 219/519
2018-06-20 18:18:59,627:INFO: Holoprosencephaly Recall-at-100: 0.00%
2018-06-20 18:18:59,627:INFO: Experiment Progress: 42.0% -- 220/519
2018-06-20 18:19:00,262:INFO: Arthritis, Experimental Recall-at-100: 15.00%
2018-06-20 18:19:00,262:INFO: Experiment Progress: 42.0% -- 221/519
2018-06-20 18:19:00,848:INFO: Congenital Heart Defects Recall-at-100: 9.17%
2018-06-20 18:19:00,848:INFO: Experiment Progress: 42.0% -- 222/519
2018-06-20 18:19:01,139:INFO: Pseudohypoaldosteronism Recall-at-100: 66.67%
2018-06-20 18:19:01,139:INFO: Experiment Progress: 42.0% -- 223/519
2018-06-20 18:19:01,567:INFO: Cataract Recall-at-100: 26.67%
2018-06-20 18:19:01,568:INFO: Experiment Progress: 43.0% -- 224/519
2018-06-20 18:19:01,975:INFO: Giant Cell Glioblastoma Recall-at-100: 15.00%
2018-06-20 18:19:01,975:INFO: Experiment Progress: 43.0% -- 225/519
2018-06-20 18:19:02,439:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-06-20 18:19:02,439:INFO: Experiment Progress: 43.0% -- 226/519
2018-06-20 18:19:02,837:INFO: Body Weight Recall-at-100: 0.00%
2018-06-20 18:19:02,837:INFO: Experiment Progress: 43.0% -- 227/519
2018-06-20 18:19:03,197:INFO: Huntington Disease Recall-at-100: 0.00%
2018-06-20 18:19:03,197:INFO: Experiment Progress: 43.0% -- 228/519
2018-06-20 18:19:03,925:INFO: Glioblastoma Recall-at-100: 16.67%
2018-06-20 18:19:03,926:INFO: Experiment Progress: 44.0% -- 229/519
2018-06-20 18:19:04,268:INFO: Congenital diaphragmatic hernia Recall-at-100: 30.00%
2018-06-20 18:19:04,268:INFO: Experiment Progress: 44.0% -- 230/519
2018-06-20 18:19:04,725:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-06-20 18:19:04,725:INFO: Experiment Progress: 44.0% -- 231/519
2018-06-20 18:19:05,509:INFO: Acute kidney injury Recall-at-100: 8.81%
2018-06-20 18:19:05,510:INFO: Experiment Progress: 44.0% -- 232/519
2018-06-20 18:19:05,857:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-06-20 18:19:05,857:INFO: Experiment Progress: 44.0% -- 233/519
2018-06-20 18:19:06,850:INFO: Spontaneous abortion Recall-at-100: 7.00%
2018-06-20 18:19:06,851:INFO: Experiment Progress: 45.0% -- 234/519
2018-06-20 18:19:07,614:INFO: Glioma Recall-at-100: 5.95%
2018-06-20 18:19:07,614:INFO: Experiment Progress: 45.0% -- 235/519
2018-06-20 18:19:07,999:INFO: Gliosis Recall-at-100: 55.00%
2018-06-20 18:19:08,000:INFO: Experiment Progress: 45.0% -- 236/519
2018-06-20 18:19:08,323:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 70.00%
2018-06-20 18:19:08,323:INFO: Experiment Progress: 45.0% -- 237/519
2018-06-20 18:19:08,614:INFO: Dementia Recall-at-100: 0.00%
2018-06-20 18:19:08,614:INFO: Experiment Progress: 45.0% -- 238/519
2018-06-20 18:19:09,062:INFO: Pancreatitis Recall-at-100: 0.00%
2018-06-20 18:19:09,063:INFO: Experiment Progress: 46.0% -- 239/519
2018-06-20 18:19:09,419:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-06-20 18:19:09,419:INFO: Experiment Progress: 46.0% -- 240/519
2018-06-20 18:19:09,912:INFO: Thyroid Neoplasm Recall-at-100: 15.83%
2018-06-20 18:19:09,912:INFO: Experiment Progress: 46.0% -- 241/519
2018-06-20 18:19:11,192:INFO: Neoplasm Invasiveness Recall-at-100: 13.97%
2018-06-20 18:19:11,192:INFO: Experiment Progress: 46.0% -- 242/519
2018-06-20 18:19:12,551:INFO: Neoplasm Metastasis Recall-at-100: 10.90%
2018-06-20 18:19:12,551:INFO: Experiment Progress: 46.0% -- 243/519
2018-06-20 18:19:12,995:INFO: Albuminuria Recall-at-100: 10.00%
2018-06-20 18:19:12,995:INFO: Experiment Progress: 47.0% -- 244/519
2018-06-20 18:19:13,406:INFO: Pre-Eclampsia Recall-at-100: 0.00%
2018-06-20 18:19:13,407:INFO: Experiment Progress: 47.0% -- 245/519
2018-06-20 18:19:14,234:INFO: Nerve Degeneration Recall-at-100: 10.00%
2018-06-20 18:19:14,234:INFO: Experiment Progress: 47.0% -- 246/519
2018-06-20 18:19:14,576:INFO: Thromboembolism Recall-at-100: 60.00%
2018-06-20 18:19:14,577:INFO: Experiment Progress: 47.0% -- 247/519
2018-06-20 18:19:15,955:INFO: Polycystic Ovary Syndrome Recall-at-100: 0.71%
2018-06-20 18:19:15,956:INFO: Experiment Progress: 47.0% -- 248/519
2018-06-20 18:19:16,293:INFO: Transient Ischemic Attack Recall-at-100: 10.00%
2018-06-20 18:19:16,293:INFO: Experiment Progress: 47.0% -- 249/519
2018-06-20 18:19:16,990:INFO: Brain Ischemia Recall-at-100: 23.33%
2018-06-20 18:19:16,991:INFO: Experiment Progress: 48.0% -- 250/519
2018-06-20 18:19:17,305:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-06-20 18:19:17,306:INFO: Experiment Progress: 48.0% -- 251/519
2018-06-20 18:19:17,708:INFO: Malignant neoplasm of esophagus Recall-at-100: 0.00%
2018-06-20 18:19:17,708:INFO: Experiment Progress: 48.0% -- 252/519
2018-06-20 18:19:18,684:INFO: Degenerative polyarthritis Recall-at-100: 12.00%
2018-06-20 18:19:18,684:INFO: Experiment Progress: 48.0% -- 253/519
2018-06-20 18:19:18,949:INFO: Osteitis Deformans Recall-at-100: 12.50%
2018-06-20 18:19:18,949:INFO: Experiment Progress: 48.0% -- 254/519
2018-06-20 18:19:19,273:INFO: Diabetic Cardiomyopathies Recall-at-100: 20.00%
2018-06-20 18:19:19,273:INFO: Experiment Progress: 49.0% -- 255/519
2018-06-20 18:19:19,617:INFO: Nuclear cataract Recall-at-100: 40.00%
2018-06-20 18:19:19,617:INFO: Experiment Progress: 49.0% -- 256/519
2018-06-20 18:19:19,959:INFO: Anorexia Recall-at-100: 35.00%
2018-06-20 18:19:19,959:INFO: Experiment Progress: 49.0% -- 257/519
2018-06-20 18:19:20,879:INFO: Cocaine-Related Disorders Recall-at-100: 6.81%
2018-06-20 18:19:20,879:INFO: Experiment Progress: 49.0% -- 258/519
2018-06-20 18:19:21,031:INFO: MELAS Syndrome Recall-at-100: 0.00%
2018-06-20 18:19:21,031:INFO: Experiment Progress: 49.0% -- 259/519
2018-06-20 18:19:21,207:INFO: Mitochondrial Myopathies Recall-at-100: 0.00%
2018-06-20 18:19:21,207:INFO: Experiment Progress: 50.0% -- 260/519
2018-06-20 18:19:21,996:INFO: Amphetamine-Related Disorders Recall-at-100: 4.29%
2018-06-20 18:19:21,996:INFO: Experiment Progress: 50.0% -- 261/519
2018-06-20 18:19:22,311:INFO: Birth Weight Recall-at-100: 0.00%
2018-06-20 18:19:22,312:INFO: Experiment Progress: 50.0% -- 262/519
2018-06-20 18:19:22,758:INFO: Brain Diseases Recall-at-100: 0.00%
2018-06-20 18:19:22,759:INFO: Experiment Progress: 50.0% -- 263/519
2018-06-20 18:19:23,138:INFO: Dyslipidemias Recall-at-100: 15.00%
2018-06-20 18:19:23,138:INFO: Experiment Progress: 50.0% -- 264/519
2018-06-20 18:19:23,423:INFO: Berylliosis Recall-at-100: 0.00%
2018-06-20 18:19:23,423:INFO: Experiment Progress: 51.0% -- 265/519
2018-06-20 18:19:23,853:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-06-20 18:19:23,853:INFO: Experiment Progress: 51.0% -- 266/519
2018-06-20 18:19:24,106:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-06-20 18:19:24,106:INFO: Experiment Progress: 51.0% -- 267/519
2018-06-20 18:19:25,173:INFO: Liver neoplasms Recall-at-100: 7.91%
2018-06-20 18:19:25,174:INFO: Experiment Progress: 51.0% -- 268/519
2018-06-20 18:19:25,814:INFO: Myocardial Reperfusion Injury Recall-at-100: 31.50%
2018-06-20 18:19:25,815:INFO: Experiment Progress: 51.0% -- 269/519
2018-06-20 18:19:26,199:INFO: Microsatellite Instability Recall-at-100: 5.00%
2018-06-20 18:19:26,199:INFO: Experiment Progress: 52.0% -- 270/519
2018-06-20 18:19:26,532:INFO: Night blindness, congenital stationary Recall-at-100: 25.00%
2018-06-20 18:19:26,533:INFO: Experiment Progress: 52.0% -- 271/519
2018-06-20 18:19:27,047:INFO: Stevens-Johnson Syndrome Recall-at-100: 36.67%
2018-06-20 18:19:27,048:INFO: Experiment Progress: 52.0% -- 272/519
2018-06-20 18:19:27,395:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-06-20 18:19:27,396:INFO: Experiment Progress: 52.0% -- 273/519
2018-06-20 18:19:28,025:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-06-20 18:19:28,025:INFO: Experiment Progress: 52.0% -- 274/519
2018-06-20 18:19:28,454:INFO: Learning Disorders Recall-at-100: 5.00%
2018-06-20 18:19:28,455:INFO: Experiment Progress: 52.0% -- 275/519
2018-06-20 18:19:28,786:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 30.00%
2018-06-20 18:19:28,786:INFO: Experiment Progress: 53.0% -- 276/519
2018-06-20 18:19:29,085:INFO: Marfan Syndrome Recall-at-100: 44.44%
2018-06-20 18:19:29,085:INFO: Experiment Progress: 53.0% -- 277/519
2018-06-20 18:19:29,427:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-06-20 18:19:29,428:INFO: Experiment Progress: 53.0% -- 278/519
2018-06-20 18:19:30,909:INFO: Lung Neoplasms Recall-at-100: 10.26%
2018-06-20 18:19:30,909:INFO: Experiment Progress: 53.0% -- 279/519
2018-06-20 18:19:31,108:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-06-20 18:19:31,108:INFO: Experiment Progress: 53.0% -- 280/519
2018-06-20 18:19:31,985:INFO: Inflammatory Bowel Diseases Recall-at-100: 3.93%
2018-06-20 18:19:31,985:INFO: Experiment Progress: 54.0% -- 281/519
2018-06-20 18:19:35,230:INFO: Mammary Neoplasms Recall-at-100: 6.37%
2018-06-20 18:19:35,230:INFO: Experiment Progress: 54.0% -- 282/519
2018-06-20 18:19:35,400:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-06-20 18:19:35,401:INFO: Experiment Progress: 54.0% -- 283/519
2018-06-20 18:19:35,698:INFO: Neuralgia Recall-at-100: 0.00%
2018-06-20 18:19:35,698:INFO: Experiment Progress: 54.0% -- 284/519
2018-06-20 18:19:36,129:INFO: Neural Tube Defects Recall-at-100: 11.67%
2018-06-20 18:19:36,129:INFO: Experiment Progress: 54.0% -- 285/519
2018-06-20 18:19:36,868:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-06-20 18:19:36,868:INFO: Experiment Progress: 55.0% -- 286/519
2018-06-20 18:19:37,221:INFO: Inborn Errors of Metabolism Recall-at-100: 15.00%
2018-06-20 18:19:37,221:INFO: Experiment Progress: 55.0% -- 287/519
2018-06-20 18:19:37,688:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-06-20 18:19:37,689:INFO: Experiment Progress: 55.0% -- 288/519
2018-06-20 18:19:38,019:INFO: Intestinal Neoplasms Recall-at-100: 35.00%
2018-06-20 18:19:38,019:INFO: Experiment Progress: 55.0% -- 289/519
2018-06-20 18:19:38,287:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-06-20 18:19:38,287:INFO: Experiment Progress: 55.0% -- 290/519
2018-06-20 18:19:38,983:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-06-20 18:19:38,983:INFO: Experiment Progress: 56.0% -- 291/519
2018-06-20 18:19:39,509:INFO: Age related macular degeneration Recall-at-100: 9.17%
2018-06-20 18:19:39,509:INFO: Experiment Progress: 56.0% -- 292/519
2018-06-20 18:19:39,932:INFO: Hyperplasia Recall-at-100: 13.33%
2018-06-20 18:19:39,932:INFO: Experiment Progress: 56.0% -- 293/519
2018-06-20 18:19:40,425:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-06-20 18:19:40,425:INFO: Experiment Progress: 56.0% -- 294/519
2018-06-20 18:19:40,766:INFO: Spina Bifida Recall-at-100: 0.00%
2018-06-20 18:19:40,766:INFO: Experiment Progress: 56.0% -- 295/519
2018-06-20 18:19:41,184:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 18.33%
2018-06-20 18:19:41,184:INFO: Experiment Progress: 57.0% -- 296/519
2018-06-20 18:19:41,599:INFO: Bardet-Biedl Syndrome Recall-at-100: 58.33%
2018-06-20 18:19:41,599:INFO: Experiment Progress: 57.0% -- 297/519
2018-06-20 18:19:42,105:INFO: Keloid Recall-at-100: 21.67%
2018-06-20 18:19:42,105:INFO: Experiment Progress: 57.0% -- 298/519
2018-06-20 18:19:43,785:INFO: melanoma Recall-at-100: 4.36%
2018-06-20 18:19:43,785:INFO: Experiment Progress: 57.0% -- 299/519
2018-06-20 18:19:44,214:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 25.00%
2018-06-20 18:19:44,214:INFO: Experiment Progress: 57.0% -- 300/519
2018-06-20 18:19:44,798:INFO: Pneumonia Recall-at-100: 18.00%
2018-06-20 18:19:44,798:INFO: Experiment Progress: 57.0% -- 301/519
2018-06-20 18:19:46,006:INFO: Disease Progression Recall-at-100: 5.64%
2018-06-20 18:19:46,007:INFO: Experiment Progress: 58.0% -- 302/519
2018-06-20 18:19:46,380:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-06-20 18:19:46,381:INFO: Experiment Progress: 58.0% -- 303/519
2018-06-20 18:19:46,726:INFO: Severe Combined Immunodeficiency Recall-at-100: 40.00%
2018-06-20 18:19:46,727:INFO: Experiment Progress: 58.0% -- 304/519
2018-06-20 18:19:47,096:INFO: Malignant neoplasm of ovary Recall-at-100: 10.00%
2018-06-20 18:19:47,096:INFO: Experiment Progress: 58.0% -- 305/519
2018-06-20 18:19:47,479:INFO: Pheochromocytoma Recall-at-100: 0.00%
2018-06-20 18:19:47,479:INFO: Experiment Progress: 58.0% -- 306/519
2018-06-20 18:19:47,907:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-06-20 18:19:47,907:INFO: Experiment Progress: 59.0% -- 307/519
2018-06-20 18:19:48,226:INFO: Hypogonadism Recall-at-100: 0.00%
2018-06-20 18:19:48,226:INFO: Experiment Progress: 59.0% -- 308/519
2018-06-20 18:19:48,641:INFO: Movement Disorders Recall-at-100: 23.33%
2018-06-20 18:19:48,641:INFO: Experiment Progress: 59.0% -- 309/519
2018-06-20 18:19:49,007:INFO: Sarcoma Recall-at-100: 15.00%
2018-06-20 18:19:49,007:INFO: Experiment Progress: 59.0% -- 310/519
2018-06-20 18:19:49,359:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-06-20 18:19:49,359:INFO: Experiment Progress: 59.0% -- 311/519
2018-06-20 18:19:49,689:INFO: Hypoglycemia Recall-at-100: 30.00%
2018-06-20 18:19:49,689:INFO: Experiment Progress: 60.0% -- 312/519
2018-06-20 18:19:50,034:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-06-20 18:19:50,034:INFO: Experiment Progress: 60.0% -- 313/519
2018-06-20 18:19:50,379:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-06-20 18:19:50,379:INFO: Experiment Progress: 60.0% -- 314/519
2018-06-20 18:19:50,819:INFO: Colorectal Cancer Recall-at-100: 10.00%
2018-06-20 18:19:50,819:INFO: Experiment Progress: 60.0% -- 315/519
2018-06-20 18:19:51,493:INFO: Atherosclerosis Recall-at-100: 5.33%
2018-06-20 18:19:51,493:INFO: Experiment Progress: 60.0% -- 316/519
2018-06-20 18:19:52,515:INFO: Asthma Recall-at-100: 4.00%
2018-06-20 18:19:52,515:INFO: Experiment Progress: 61.0% -- 317/519
2018-06-20 18:19:52,935:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 38.33%
2018-06-20 18:19:52,935:INFO: Experiment Progress: 61.0% -- 318/519
2018-06-20 18:19:53,486:INFO: Skin Neoplasms Recall-at-100: 18.00%
2018-06-20 18:19:53,486:INFO: Experiment Progress: 61.0% -- 319/519
2018-06-20 18:19:54,443:INFO: Seizures Recall-at-100: 1.11%
2018-06-20 18:19:54,443:INFO: Experiment Progress: 61.0% -- 320/519
2018-06-20 18:19:55,752:INFO: Alzheimer's Disease Recall-at-100: 7.36%
2018-06-20 18:19:55,752:INFO: Experiment Progress: 61.0% -- 321/519
2018-06-20 18:19:56,143:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-06-20 18:19:56,144:INFO: Experiment Progress: 62.0% -- 322/519
2018-06-20 18:19:56,781:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 33.00%
2018-06-20 18:19:56,781:INFO: Experiment Progress: 62.0% -- 323/519
2018-06-20 18:19:57,165:INFO: Gastrointestinal Diseases Recall-at-100: 10.00%
2018-06-20 18:19:57,165:INFO: Experiment Progress: 62.0% -- 324/519
2018-06-20 18:19:57,546:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 25.00%
2018-06-20 18:19:57,547:INFO: Experiment Progress: 62.0% -- 325/519
2018-06-20 18:19:57,951:INFO: Retinal Degeneration Recall-at-100: 0.00%
2018-06-20 18:19:57,951:INFO: Experiment Progress: 62.0% -- 326/519
2018-06-20 18:19:58,433:INFO: Retinal Diseases Recall-at-100: 13.33%
2018-06-20 18:19:58,433:INFO: Experiment Progress: 63.0% -- 327/519
2018-06-20 18:19:58,746:INFO: Methylmalonic acidemia Recall-at-100: 22.22%
2018-06-20 18:19:58,746:INFO: Experiment Progress: 63.0% -- 328/519
2018-06-20 18:19:59,618:INFO: Contact Dermatitis Recall-at-100: 8.57%
2018-06-20 18:19:59,619:INFO: Experiment Progress: 63.0% -- 329/519
2018-06-20 18:20:00,265:INFO: Dermatitis, Atopic Recall-at-100: 10.00%
2018-06-20 18:20:00,265:INFO: Experiment Progress: 63.0% -- 330/519
2018-06-20 18:20:00,974:INFO: Coronary heart disease Recall-at-100: 0.00%
2018-06-20 18:20:00,974:INFO: Experiment Progress: 63.0% -- 331/519
2018-06-20 18:20:01,874:INFO: Osteoporosis Recall-at-100: 12.38%
2018-06-20 18:20:01,874:INFO: Experiment Progress: 63.0% -- 332/519
2018-06-20 18:20:02,747:INFO: Cardiomegaly Recall-at-100: 11.19%
2018-06-20 18:20:02,747:INFO: Experiment Progress: 64.0% -- 333/519
2018-06-20 18:20:03,713:INFO: Heart failure Recall-at-100: 3.93%
2018-06-20 18:20:03,713:INFO: Experiment Progress: 64.0% -- 334/519
2018-06-20 18:20:04,109:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 95.00%
2018-06-20 18:20:04,110:INFO: Experiment Progress: 64.0% -- 335/519
2018-06-20 18:20:04,662:INFO: Major Depressive Disorder Recall-at-100: 0.00%
2018-06-20 18:20:04,662:INFO: Experiment Progress: 64.0% -- 336/519
2018-06-20 18:20:05,519:INFO: Dermatologic disorders Recall-at-100: 1.43%
2018-06-20 18:20:05,519:INFO: Experiment Progress: 64.0% -- 337/519
2018-06-20 18:20:06,746:INFO: Inflammation Recall-at-100: 6.64%
2018-06-20 18:20:06,747:INFO: Experiment Progress: 65.0% -- 338/519
2018-06-20 18:20:07,141:INFO: Diabetic Neuropathies Recall-at-100: 25.00%
2018-06-20 18:20:07,141:INFO: Experiment Progress: 65.0% -- 339/519
2018-06-20 18:20:07,783:INFO: Male infertility Recall-at-100: 15.00%
2018-06-20 18:20:07,783:INFO: Experiment Progress: 65.0% -- 340/519
2018-06-20 18:20:08,201:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-06-20 18:20:08,202:INFO: Experiment Progress: 65.0% -- 341/519
2018-06-20 18:20:08,695:INFO: Female infertility Recall-at-100: 33.33%
2018-06-20 18:20:08,695:INFO: Experiment Progress: 65.0% -- 342/519
2018-06-20 18:20:09,258:INFO: leukemia Recall-at-100: 20.00%
2018-06-20 18:20:09,258:INFO: Experiment Progress: 66.0% -- 343/519
2018-06-20 18:20:10,262:INFO: Ulcerative Colitis Recall-at-100: 8.75%
2018-06-20 18:20:10,263:INFO: Experiment Progress: 66.0% -- 344/519
2018-06-20 18:20:11,102:INFO: Influenza Recall-at-100: 22.50%
2018-06-20 18:20:11,102:INFO: Experiment Progress: 66.0% -- 345/519
2018-06-20 18:20:11,394:INFO: Nephritis, Interstitial Recall-at-100: 44.44%
2018-06-20 18:20:11,395:INFO: Experiment Progress: 66.0% -- 346/519
2018-06-20 18:20:11,774:INFO: Sjogren's Syndrome Recall-at-100: 0.00%
2018-06-20 18:20:11,774:INFO: Experiment Progress: 66.0% -- 347/519
2018-06-20 18:20:12,124:INFO: Infant length Recall-at-100: 10.00%
2018-06-20 18:20:12,125:INFO: Experiment Progress: 67.0% -- 348/519
2018-06-20 18:20:12,847:INFO: Child Development Disorders, Pervasive Recall-at-100: 7.67%
2018-06-20 18:20:12,848:INFO: Experiment Progress: 67.0% -- 349/519
2018-06-20 18:20:13,627:INFO: Substance Withdrawal Syndrome Recall-at-100: 10.50%
2018-06-20 18:20:13,628:INFO: Experiment Progress: 67.0% -- 350/519
2018-06-20 18:20:14,059:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-06-20 18:20:14,059:INFO: Experiment Progress: 67.0% -- 351/519
2018-06-20 18:20:14,977:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 9.29%
2018-06-20 18:20:14,977:INFO: Experiment Progress: 67.0% -- 352/519
2018-06-20 18:20:15,439:INFO: Developmental Disabilities Recall-at-100: 5.00%
2018-06-20 18:20:15,439:INFO: Experiment Progress: 68.0% -- 353/519
2018-06-20 18:20:15,806:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-06-20 18:20:15,806:INFO: Experiment Progress: 68.0% -- 354/519
2018-06-20 18:20:16,307:INFO: Cholestasis Recall-at-100: 10.83%
2018-06-20 18:20:16,307:INFO: Experiment Progress: 68.0% -- 355/519
2018-06-20 18:20:16,780:INFO: Pulmonary Hypertension Recall-at-100: 0.00%
2018-06-20 18:20:16,780:INFO: Experiment Progress: 68.0% -- 356/519
2018-06-20 18:20:17,256:INFO: Papillary thyroid carcinoma Recall-at-100: 6.67%
2018-06-20 18:20:17,256:INFO: Experiment Progress: 68.0% -- 357/519
2018-06-20 18:20:17,898:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-06-20 18:20:17,899:INFO: Experiment Progress: 68.0% -- 358/519
2018-06-20 18:20:18,495:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 8.33%
2018-06-20 18:20:18,495:INFO: Experiment Progress: 69.0% -- 359/519
2018-06-20 18:20:18,885:INFO: Hay fever Recall-at-100: 0.00%
2018-06-20 18:20:18,886:INFO: Experiment Progress: 69.0% -- 360/519
2018-06-20 18:20:19,325:INFO: Hypercholesterolemia, Familial Recall-at-100: 35.00%
2018-06-20 18:20:19,326:INFO: Experiment Progress: 69.0% -- 361/519
2018-06-20 18:20:20,428:INFO: Down Syndrome Recall-at-100: 1.11%
2018-06-20 18:20:20,428:INFO: Experiment Progress: 69.0% -- 362/519
2018-06-20 18:20:20,805:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 40.00%
2018-06-20 18:20:20,805:INFO: Experiment Progress: 69.0% -- 363/519
2018-06-20 18:20:21,209:INFO: Semilobar Holoprosencephaly Recall-at-100: 0.00%
2018-06-20 18:20:21,209:INFO: Experiment Progress: 70.0% -- 364/519
2018-06-20 18:20:21,624:INFO: Hypertriglyceridemia Recall-at-100: 0.00%
2018-06-20 18:20:21,624:INFO: Experiment Progress: 70.0% -- 365/519
2018-06-20 18:20:21,970:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 22.22%
2018-06-20 18:20:21,970:INFO: Experiment Progress: 70.0% -- 366/519
2018-06-20 18:20:22,601:INFO: Metabolic Syndrome X Recall-at-100: 7.00%
2018-06-20 18:20:22,602:INFO: Experiment Progress: 70.0% -- 367/519
2018-06-20 18:20:23,038:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-06-20 18:20:23,038:INFO: Experiment Progress: 70.0% -- 368/519
2018-06-20 18:20:24,329:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 3.64%
2018-06-20 18:20:24,329:INFO: Experiment Progress: 71.0% -- 369/519
2018-06-20 18:20:25,110:INFO: Malignant neoplasm of prostate Recall-at-100: 4.76%
2018-06-20 18:20:25,110:INFO: Experiment Progress: 71.0% -- 370/519
2018-06-20 18:20:25,433:INFO: Renal Insufficiency Recall-at-100: 0.00%
2018-06-20 18:20:25,433:INFO: Experiment Progress: 71.0% -- 371/519
2018-06-20 18:20:25,750:INFO: Jeune thoracic dystrophy Recall-at-100: 77.78%
2018-06-20 18:20:25,750:INFO: Experiment Progress: 71.0% -- 372/519
2018-06-20 18:20:26,937:INFO: Renal Cell Carcinoma Recall-at-100: 5.91%
2018-06-20 18:20:26,937:INFO: Experiment Progress: 71.0% -- 373/519
2018-06-20 18:20:27,879:INFO: Squamous cell carcinoma Recall-at-100: 14.86%
2018-06-20 18:20:27,879:INFO: Experiment Progress: 72.0% -- 374/519
2018-06-20 18:20:28,946:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 8.36%
2018-06-20 18:20:28,946:INFO: Experiment Progress: 72.0% -- 375/519
2018-06-20 18:20:29,302:INFO: Manganese Poisoning Recall-at-100: 0.00%
2018-06-20 18:20:29,302:INFO: Experiment Progress: 72.0% -- 376/519
2018-06-20 18:20:29,687:INFO: Ventricular Dysfunction, Left Recall-at-100: 0.00%
2018-06-20 18:20:29,687:INFO: Experiment Progress: 72.0% -- 377/519
2018-06-20 18:20:30,169:INFO: Carcinoma, Transitional Cell Recall-at-100: 25.00%
2018-06-20 18:20:30,170:INFO: Experiment Progress: 72.0% -- 378/519
2018-06-20 18:20:30,452:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-06-20 18:20:30,452:INFO: Experiment Progress: 73.0% -- 379/519
2018-06-20 18:20:30,790:INFO: Tobacco Use Disorder Recall-at-100: 0.00%
2018-06-20 18:20:30,790:INFO: Experiment Progress: 73.0% -- 380/519
2018-06-20 18:20:31,308:INFO: Proteinuria Recall-at-100: 13.33%
2018-06-20 18:20:31,309:INFO: Experiment Progress: 73.0% -- 381/519
2018-06-20 18:20:31,820:INFO: Diabetic Nephropathy Recall-at-100: 10.83%
2018-06-20 18:20:31,821:INFO: Experiment Progress: 73.0% -- 382/519
2018-06-20 18:20:32,106:INFO: Williams Syndrome Recall-at-100: 11.11%
2018-06-20 18:20:32,107:INFO: Experiment Progress: 73.0% -- 383/519
2018-06-20 18:20:32,478:INFO: Oral Submucous Fibrosis Recall-at-100: 45.00%
2018-06-20 18:20:32,478:INFO: Experiment Progress: 73.0% -- 384/519
2018-06-20 18:20:32,972:INFO: Adenoma Recall-at-100: 6.67%
2018-06-20 18:20:32,972:INFO: Experiment Progress: 74.0% -- 385/519
2018-06-20 18:20:33,313:INFO: Neutropenia Recall-at-100: 0.00%
2018-06-20 18:20:33,313:INFO: Experiment Progress: 74.0% -- 386/519
2018-06-20 18:20:33,674:INFO: Poor school performance Recall-at-100: 0.00%
2018-06-20 18:20:33,674:INFO: Experiment Progress: 74.0% -- 387/519
2018-06-20 18:20:34,054:INFO: Pneumoconiosis Recall-at-100: 15.00%
2018-06-20 18:20:34,055:INFO: Experiment Progress: 74.0% -- 388/519
2018-06-20 18:20:34,679:INFO: Cardiovascular Diseases Recall-at-100: 10.00%
2018-06-20 18:20:34,679:INFO: Experiment Progress: 74.0% -- 389/519
2018-06-20 18:20:35,060:INFO: Fibrinogen Adverse Event Recall-at-100: 20.00%
2018-06-20 18:20:35,060:INFO: Experiment Progress: 75.0% -- 390/519
2018-06-20 18:20:36,478:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 4.62%
2018-06-20 18:20:36,478:INFO: Experiment Progress: 75.0% -- 391/519
2018-06-20 18:20:36,901:INFO: Thrombocytopenia Recall-at-100: 10.00%
2018-06-20 18:20:36,902:INFO: Experiment Progress: 75.0% -- 392/519
2018-06-20 18:20:37,364:INFO: Sezary Syndrome Recall-at-100: 25.00%
2018-06-20 18:20:37,365:INFO: Experiment Progress: 75.0% -- 393/519
2018-06-20 18:20:37,690:INFO: Nuclear non-senile cataract Recall-at-100: 40.00%
2018-06-20 18:20:37,691:INFO: Experiment Progress: 75.0% -- 394/519
2018-06-20 18:20:38,141:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-06-20 18:20:38,141:INFO: Experiment Progress: 76.0% -- 395/519
2018-06-20 18:20:38,688:INFO: hearing impairment Recall-at-100: 0.00%
2018-06-20 18:20:38,688:INFO: Experiment Progress: 76.0% -- 396/519
2018-06-20 18:20:39,073:INFO: Psychotic Disorders Recall-at-100: 10.00%
2018-06-20 18:20:39,073:INFO: Experiment Progress: 76.0% -- 397/519
2018-06-20 18:20:39,563:INFO: Anxiety Disorders Recall-at-100: 20.00%
2018-06-20 18:20:39,563:INFO: Experiment Progress: 76.0% -- 398/519
2018-06-20 18:20:39,976:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 15.00%
2018-06-20 18:20:39,976:INFO: Experiment Progress: 76.0% -- 399/519
2018-06-20 18:20:40,360:INFO: Motion Sickness Recall-at-100: 25.00%
2018-06-20 18:20:40,360:INFO: Experiment Progress: 77.0% -- 400/519
2018-06-20 18:20:40,762:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 5.00%
2018-06-20 18:20:40,762:INFO: Experiment Progress: 77.0% -- 401/519
2018-06-20 18:20:41,153:INFO: Lymphoma, Follicular Recall-at-100: 5.00%
2018-06-20 18:20:41,153:INFO: Experiment Progress: 77.0% -- 402/519
2018-06-20 18:20:41,502:INFO: Thrombocythemia, Essential Recall-at-100: 15.00%
2018-06-20 18:20:41,503:INFO: Experiment Progress: 77.0% -- 403/519
2018-06-20 18:20:41,791:INFO: Arthritis Recall-at-100: 0.00%
2018-06-20 18:20:41,791:INFO: Experiment Progress: 77.0% -- 404/519
2018-06-20 18:20:42,376:INFO: Hypotension Recall-at-100: 9.67%
2018-06-20 18:20:42,376:INFO: Experiment Progress: 78.0% -- 405/519
2018-06-20 18:20:43,272:INFO: Reperfusion Injury Recall-at-100: 14.17%
2018-06-20 18:20:43,272:INFO: Experiment Progress: 78.0% -- 406/519
2018-06-20 18:20:43,604:INFO: Heat Stroke Recall-at-100: 70.00%
2018-06-20 18:20:43,604:INFO: Experiment Progress: 78.0% -- 407/519
2018-06-20 18:20:43,990:INFO: Hemangiosarcoma Recall-at-100: 50.00%
2018-06-20 18:20:43,991:INFO: Experiment Progress: 78.0% -- 408/519
2018-06-20 18:20:44,487:INFO: Drug Allergy Recall-at-100: 0.00%
2018-06-20 18:20:44,487:INFO: Experiment Progress: 78.0% -- 409/519
2018-06-20 18:20:44,845:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 0.00%
2018-06-20 18:20:44,845:INFO: Experiment Progress: 78.0% -- 410/519
2018-06-20 18:20:45,442:INFO: Medulloblastoma Recall-at-100: 14.50%
2018-06-20 18:20:45,442:INFO: Experiment Progress: 79.0% -- 411/519
2018-06-20 18:20:45,869:INFO: Cleft Lip Recall-at-100: 31.67%
2018-06-20 18:20:45,869:INFO: Experiment Progress: 79.0% -- 412/519
2018-06-20 18:20:46,454:INFO: Cleft Palate Recall-at-100: 25.00%
2018-06-20 18:20:46,454:INFO: Experiment Progress: 79.0% -- 413/519
2018-06-20 18:20:47,377:INFO: Muscle Weakness Recall-at-100: 1.25%
2018-06-20 18:20:47,377:INFO: Experiment Progress: 79.0% -- 414/519
2018-06-20 18:20:47,712:INFO: Mental disorders Recall-at-100: 0.00%
2018-06-20 18:20:47,712:INFO: Experiment Progress: 79.0% -- 415/519
2018-06-20 18:20:48,146:INFO: Astrocytoma Recall-at-100: 35.00%
2018-06-20 18:20:48,146:INFO: Experiment Progress: 80.0% -- 416/519
2018-06-20 18:20:48,505:INFO: Anemia, Diamond-Blackfan Recall-at-100: 85.00%
2018-06-20 18:20:48,505:INFO: Experiment Progress: 80.0% -- 417/519
2018-06-20 18:20:48,850:INFO: Asthma, Aspirin-Induced Recall-at-100: 10.00%
2018-06-20 18:20:48,850:INFO: Experiment Progress: 80.0% -- 418/519
2018-06-20 18:20:49,255:INFO: Leber Congenital Amaurosis Recall-at-100: 10.00%
2018-06-20 18:20:49,255:INFO: Experiment Progress: 80.0% -- 419/519
2018-06-20 18:20:49,577:INFO: Cachexia Recall-at-100: 20.00%
2018-06-20 18:20:49,577:INFO: Experiment Progress: 80.0% -- 420/519
2018-06-20 18:20:49,912:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-06-20 18:20:49,912:INFO: Experiment Progress: 81.0% -- 421/519
2018-06-20 18:20:50,278:INFO: Respiratory Hypersensitivity Recall-at-100: 10.00%
2018-06-20 18:20:50,278:INFO: Experiment Progress: 81.0% -- 422/519
2018-06-20 18:20:50,695:INFO: Nasopharyngeal carcinoma Recall-at-100: 20.00%
2018-06-20 18:20:50,695:INFO: Experiment Progress: 81.0% -- 423/519
2018-06-20 18:20:51,388:INFO: Hyperalgesia Recall-at-100: 9.29%
2018-06-20 18:20:51,388:INFO: Experiment Progress: 81.0% -- 424/519
2018-06-20 18:20:51,755:INFO: Meningioma Recall-at-100: 10.00%
2018-06-20 18:20:51,755:INFO: Experiment Progress: 81.0% -- 425/519
2018-06-20 18:20:52,131:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-06-20 18:20:52,131:INFO: Experiment Progress: 82.0% -- 426/519
2018-06-20 18:20:53,338:INFO: Intellectual Disability Recall-at-100: 1.54%
2018-06-20 18:20:53,339:INFO: Experiment Progress: 82.0% -- 427/519
2018-06-20 18:20:53,720:INFO: Graves Disease Recall-at-100: 10.00%
2018-06-20 18:20:53,721:INFO: Experiment Progress: 82.0% -- 428/519
2018-06-20 18:20:54,155:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-06-20 18:20:54,156:INFO: Experiment Progress: 82.0% -- 429/519
2018-06-20 18:20:54,484:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 60.00%
2018-06-20 18:20:54,484:INFO: Experiment Progress: 82.0% -- 430/519
2018-06-20 18:20:54,919:INFO: Atrial Fibrillation Recall-at-100: 13.33%
2018-06-20 18:20:54,919:INFO: Experiment Progress: 83.0% -- 431/519
2018-06-20 18:20:55,322:INFO: Hepatitis, Chronic Recall-at-100: 10.00%
2018-06-20 18:20:55,322:INFO: Experiment Progress: 83.0% -- 432/519
2018-06-20 18:20:55,897:INFO: Behcet Syndrome Recall-at-100: 8.33%
2018-06-20 18:20:55,897:INFO: Experiment Progress: 83.0% -- 433/519
2018-06-20 18:20:56,767:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 7.14%
2018-06-20 18:20:56,767:INFO: Experiment Progress: 83.0% -- 434/519
2018-06-20 18:20:57,775:INFO: Diabetes Mellitus, Experimental Recall-at-100: 4.91%
2018-06-20 18:20:57,775:INFO: Experiment Progress: 83.0% -- 435/519
2018-06-20 18:20:58,224:INFO: Parkinsonian Disorders Recall-at-100: 15.00%
2018-06-20 18:20:58,224:INFO: Experiment Progress: 84.0% -- 436/519
2018-06-20 18:20:58,826:INFO: Necrosis Recall-at-100: 6.00%
2018-06-20 18:20:58,826:INFO: Experiment Progress: 84.0% -- 437/519
2018-06-20 18:20:59,166:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-06-20 18:20:59,166:INFO: Experiment Progress: 84.0% -- 438/519
2018-06-20 18:20:59,525:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-06-20 18:20:59,525:INFO: Experiment Progress: 84.0% -- 439/519
2018-06-20 18:21:00,184:INFO: Hypersensitivity Recall-at-100: 13.33%
2018-06-20 18:21:00,184:INFO: Experiment Progress: 84.0% -- 440/519
2018-06-20 18:21:00,647:INFO: Myopia Recall-at-100: 0.00%
2018-06-20 18:21:00,647:INFO: Experiment Progress: 84.0% -- 441/519
2018-06-20 18:21:01,028:INFO: Hyperemia Recall-at-100: 15.00%
2018-06-20 18:21:01,028:INFO: Experiment Progress: 85.0% -- 442/519
2018-06-20 18:21:01,549:INFO: Tooth Abnormalities Recall-at-100: 40.00%
2018-06-20 18:21:01,550:INFO: Experiment Progress: 85.0% -- 443/519
2018-06-20 18:21:02,123:INFO: Hyperglycemia Recall-at-100: 10.00%
2018-06-20 18:21:02,123:INFO: Experiment Progress: 85.0% -- 444/519
2018-06-20 18:21:02,534:INFO: Noonan Syndrome Recall-at-100: 60.00%
2018-06-20 18:21:02,534:INFO: Experiment Progress: 85.0% -- 445/519
2018-06-20 18:21:02,939:INFO: Hyperinsulinism Recall-at-100: 15.00%
2018-06-20 18:21:02,939:INFO: Experiment Progress: 85.0% -- 446/519
2018-06-20 18:21:03,443:INFO: Edema Recall-at-100: 13.33%
2018-06-20 18:21:03,443:INFO: Experiment Progress: 86.0% -- 447/519
2018-06-20 18:21:03,798:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-06-20 18:21:03,798:INFO: Experiment Progress: 86.0% -- 448/519
2018-06-20 18:21:04,178:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-06-20 18:21:04,178:INFO: Experiment Progress: 86.0% -- 449/519
2018-06-20 18:21:04,614:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-06-20 18:21:04,614:INFO: Experiment Progress: 86.0% -- 450/519
2018-06-20 18:21:04,937:INFO: Tachycardia, Ventricular Recall-at-100: 0.00%
2018-06-20 18:21:04,937:INFO: Experiment Progress: 86.0% -- 451/519
2018-06-20 18:21:05,298:INFO: Dystonia Recall-at-100: 0.00%
2018-06-20 18:21:05,298:INFO: Experiment Progress: 87.0% -- 452/519
2018-06-20 18:21:05,741:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 8.33%
2018-06-20 18:21:05,741:INFO: Experiment Progress: 87.0% -- 453/519
2018-06-20 18:21:06,063:INFO: Pulmonary Embolism Recall-at-100: 35.00%
2018-06-20 18:21:06,064:INFO: Experiment Progress: 87.0% -- 454/519
2018-06-20 18:21:06,607:INFO: Pulmonary Fibrosis Recall-at-100: 29.00%
2018-06-20 18:21:06,607:INFO: Experiment Progress: 87.0% -- 455/519
2018-06-20 18:21:06,949:INFO: West Syndrome Recall-at-100: 15.00%
2018-06-20 18:21:06,949:INFO: Experiment Progress: 87.0% -- 456/519
2018-06-20 18:21:07,385:INFO: Cerebral Hemorrhage Recall-at-100: 50.00%
2018-06-20 18:21:07,385:INFO: Experiment Progress: 88.0% -- 457/519
2018-06-20 18:21:07,740:INFO: Romano-Ward Syndrome Recall-at-100: 50.00%
2018-06-20 18:21:07,740:INFO: Experiment Progress: 88.0% -- 458/519
2018-06-20 18:21:08,287:INFO: Mouth Neoplasms Recall-at-100: 17.50%
2018-06-20 18:21:08,287:INFO: Experiment Progress: 88.0% -- 459/519
2018-06-20 18:21:08,875:INFO: Liver Cirrhosis Recall-at-100: 21.00%
2018-06-20 18:21:08,875:INFO: Experiment Progress: 88.0% -- 460/519
2018-06-20 18:21:09,318:INFO: Neoplasm Recurrence, Local Recall-at-100: 10.00%
2018-06-20 18:21:09,318:INFO: Experiment Progress: 88.0% -- 461/519
2018-06-20 18:21:11,403:INFO: Obesity Recall-at-100: 1.54%
2018-06-20 18:21:11,403:INFO: Experiment Progress: 89.0% -- 462/519
2018-06-20 18:21:11,908:INFO: Biliary cirrhosis Recall-at-100: 6.67%
2018-06-20 18:21:11,908:INFO: Experiment Progress: 89.0% -- 463/519
2018-06-20 18:21:12,520:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 18.33%
2018-06-20 18:21:12,520:INFO: Experiment Progress: 89.0% -- 464/519
2018-06-20 18:21:13,415:INFO: Cardiomyopathies Recall-at-100: 8.06%
2018-06-20 18:21:13,416:INFO: Experiment Progress: 89.0% -- 465/519
2018-06-20 18:21:13,767:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-06-20 18:21:13,767:INFO: Experiment Progress: 89.0% -- 466/519
2018-06-20 18:21:14,109:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-06-20 18:21:14,109:INFO: Experiment Progress: 89.0% -- 467/519
2018-06-20 18:21:14,466:INFO: Uremia Recall-at-100: 15.00%
2018-06-20 18:21:14,466:INFO: Experiment Progress: 90.0% -- 468/519
2018-06-20 18:21:14,957:INFO: Depressive disorder Recall-at-100: 3.33%
2018-06-20 18:21:14,957:INFO: Experiment Progress: 90.0% -- 469/519
2018-06-20 18:21:15,490:INFO: Thrombosis Recall-at-100: 33.33%
2018-06-20 18:21:15,490:INFO: Experiment Progress: 90.0% -- 470/519
2018-06-20 18:21:16,132:INFO: nervous system disorder Recall-at-100: 2.00%
2018-06-20 18:21:16,132:INFO: Experiment Progress: 90.0% -- 471/519
2018-06-20 18:21:16,508:INFO: Lymphoma Recall-at-100: 10.00%
2018-06-20 18:21:16,509:INFO: Experiment Progress: 90.0% -- 472/519
2018-06-20 18:21:19,928:INFO: IGA Glomerulonephritis Recall-at-100: 1.68%
2018-06-20 18:21:19,928:INFO: Experiment Progress: 91.0% -- 473/519
2018-06-20 18:21:20,366:INFO: Kidney Neoplasm Recall-at-100: 23.33%
2018-06-20 18:21:20,366:INFO: Experiment Progress: 91.0% -- 474/519
2018-06-20 18:21:20,632:INFO: Hypothermia, natural Recall-at-100: 0.00%
2018-06-20 18:21:20,632:INFO: Experiment Progress: 91.0% -- 475/519
2018-06-20 18:21:21,029:INFO: Focal glomerulosclerosis Recall-at-100: 21.67%
2018-06-20 18:21:21,029:INFO: Experiment Progress: 91.0% -- 476/519
2018-06-20 18:21:21,364:INFO: Hepatitis B, Chronic Recall-at-100: 15.00%
2018-06-20 18:21:21,364:INFO: Experiment Progress: 91.0% -- 477/519
2018-06-20 18:21:21,711:INFO: Drug Eruptions Recall-at-100: 5.00%
2018-06-20 18:21:21,712:INFO: Experiment Progress: 92.0% -- 478/519
2018-06-20 18:21:22,041:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-06-20 18:21:22,042:INFO: Experiment Progress: 92.0% -- 479/519
2018-06-20 18:21:24,196:INFO: Stomach Neoplasms Recall-at-100: 4.71%
2018-06-20 18:21:24,197:INFO: Experiment Progress: 92.0% -- 480/519
2018-06-20 18:21:24,722:INFO: Osteosarcoma Recall-at-100: 19.17%
2018-06-20 18:21:24,722:INFO: Experiment Progress: 92.0% -- 481/519
2018-06-20 18:21:25,202:INFO: Vitiligo Recall-at-100: 0.00%
2018-06-20 18:21:25,202:INFO: Experiment Progress: 92.0% -- 482/519
2018-06-20 18:21:25,598:INFO: Gastric ulcer Recall-at-100: 10.00%
2018-06-20 18:21:25,598:INFO: Experiment Progress: 93.0% -- 483/519
2018-06-20 18:21:26,356:INFO: Malignant neoplasm of breast Recall-at-100: 9.76%
2018-06-20 18:21:26,356:INFO: Experiment Progress: 93.0% -- 484/519
2018-06-20 18:21:27,469:INFO: Drug-Induced Liver Injury Recall-at-100: 2.37%
2018-06-20 18:21:27,469:INFO: Experiment Progress: 93.0% -- 485/519
2018-06-20 18:21:27,872:INFO: Colitis Recall-at-100: 3.33%
2018-06-20 18:21:27,872:INFO: Experiment Progress: 93.0% -- 486/519
2018-06-20 18:21:28,259:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 10.00%
2018-06-20 18:21:28,259:INFO: Experiment Progress: 93.0% -- 487/519
2018-06-20 18:21:28,609:INFO: T-Cell Lymphoma Recall-at-100: 40.00%
2018-06-20 18:21:28,609:INFO: Experiment Progress: 94.0% -- 488/519
2018-06-20 18:21:29,063:INFO: Hyperactive behavior Recall-at-100: 13.33%
2018-06-20 18:21:29,063:INFO: Experiment Progress: 94.0% -- 489/519
2018-06-20 18:21:29,387:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-06-20 18:21:29,387:INFO: Experiment Progress: 94.0% -- 490/519
2018-06-20 18:21:29,767:INFO: Epithelial ovarian cancer Recall-at-100: 10.00%
2018-06-20 18:21:29,767:INFO: Experiment Progress: 94.0% -- 491/519
2018-06-20 18:21:30,107:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-06-20 18:21:30,108:INFO: Experiment Progress: 94.0% -- 492/519
2018-06-20 18:21:30,439:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-06-20 18:21:30,439:INFO: Experiment Progress: 94.0% -- 493/519
2018-06-20 18:21:30,764:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-06-20 18:21:30,764:INFO: Experiment Progress: 95.0% -- 494/519
2018-06-20 18:21:31,144:INFO: Female Urogenital Diseases Recall-at-100: 25.00%
2018-06-20 18:21:31,144:INFO: Experiment Progress: 95.0% -- 495/519
2018-06-20 18:21:32,129:INFO: ovarian neoplasm Recall-at-100: 15.89%
2018-06-20 18:21:32,129:INFO: Experiment Progress: 95.0% -- 496/519
2018-06-20 18:21:32,469:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 0.00%
2018-06-20 18:21:32,469:INFO: Experiment Progress: 95.0% -- 497/519
2018-06-20 18:21:32,874:INFO: Venous Thrombosis Recall-at-100: 55.00%
2018-06-20 18:21:32,874:INFO: Experiment Progress: 95.0% -- 498/519
2018-06-20 18:21:33,234:INFO: Amnesia Recall-at-100: 15.00%
2018-06-20 18:21:33,234:INFO: Experiment Progress: 96.0% -- 499/519
2018-06-20 18:21:34,263:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-06-20 18:21:34,263:INFO: Experiment Progress: 96.0% -- 500/519
2018-06-20 18:21:34,631:INFO: Hemorrhage Recall-at-100: 15.00%
2018-06-20 18:21:34,631:INFO: Experiment Progress: 96.0% -- 501/519
2018-06-20 18:21:35,356:INFO: Status Epilepticus Recall-at-100: 15.00%
2018-06-20 18:21:35,357:INFO: Experiment Progress: 96.0% -- 502/519
2018-06-20 18:21:35,789:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-06-20 18:21:35,789:INFO: Experiment Progress: 96.0% -- 503/519
2018-06-20 18:21:36,195:INFO: Myeloid Leukemia, Chronic Recall-at-100: 25.00%
2018-06-20 18:21:36,195:INFO: Experiment Progress: 97.0% -- 504/519
2018-06-20 18:21:36,566:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-06-20 18:21:36,566:INFO: Experiment Progress: 97.0% -- 505/519
2018-06-20 18:21:37,107:INFO: Calcinosis Recall-at-100: 5.83%
2018-06-20 18:21:37,107:INFO: Experiment Progress: 97.0% -- 506/519
2018-06-20 18:21:37,469:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-06-20 18:21:37,470:INFO: Experiment Progress: 97.0% -- 507/519
2018-06-20 18:21:37,891:INFO: Left ventricular noncompaction Recall-at-100: 25.00%
2018-06-20 18:21:37,891:INFO: Experiment Progress: 97.0% -- 508/519
2018-06-20 18:21:38,765:INFO: Parkinson Disease Recall-at-100: 9.67%
2018-06-20 18:21:38,765:INFO: Experiment Progress: 98.0% -- 509/519
2018-06-20 18:21:39,376:INFO: Endometrial Neoplasms Recall-at-100: 8.00%
2018-06-20 18:21:39,376:INFO: Experiment Progress: 98.0% -- 510/519
2018-06-20 18:21:39,764:INFO: Sepsis Recall-at-100: 10.00%
2018-06-20 18:21:39,764:INFO: Experiment Progress: 98.0% -- 511/519
2018-06-20 18:21:41,125:INFO: Endometriosis Recall-at-100: 11.52%
2018-06-20 18:21:41,126:INFO: Experiment Progress: 98.0% -- 512/519
2018-06-20 18:21:41,880:INFO: Esophageal Neoplasms Recall-at-100: 13.10%
2018-06-20 18:21:41,880:INFO: Experiment Progress: 98.0% -- 513/519
2018-06-20 18:21:42,248:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-06-20 18:21:42,249:INFO: Experiment Progress: 99.0% -- 514/519
2018-06-20 18:21:42,675:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 0.00%
2018-06-20 18:21:42,675:INFO: Experiment Progress: 99.0% -- 515/519
2018-06-20 18:21:43,061:INFO: Lewy Body Disease Recall-at-100: 40.00%
2018-06-20 18:21:43,062:INFO: Experiment Progress: 99.0% -- 516/519
2018-06-20 18:21:43,418:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 0.00%
2018-06-20 18:21:43,418:INFO: Experiment Progress: 99.0% -- 517/519
2018-06-20 18:21:44,263:INFO: Neoplastic Cell Transformation Recall-at-100: 19.17%
2018-06-20 18:21:44,263:INFO: Experiment Progress: 99.0% -- 518/519
2018-06-20 18:21:44,947:INFO: Arsenic Poisoning Recall-at-100: 5.67%
